About Us

MSN Group is one of the fastest growing manufacturers of Active Pharmaceutical Ingredients (APIs) and Finished dosages in India. Established in the year 2003, MSN Group comprises of five API manufacturing plants ( including one for Oncology), one finished dosage facility ( one more for Oncology being built) and a dedicated R&D Center center going to be operational by Nov 2011. Our plants are ISO 9001-2000 certified, WHO: GMP, EU:GMP and USFDA approved. Our manufacturing units are designed to confirm to the principles of Quality, Safety and sound Environment.

MSN Group management team comprises of top notch professionals, with extensive experience in synthetic chemistry, process engineering, quality, IT, SCM, marketing, regulatory requirements and environmental safety and a proven track record in pharmaceutical industry. Our outstanding teams of well-educated, motivated and result-oriented employees have contributed actively to our spectacular growth.

Thriving on the platform of innovation and excellence, we have grown into a successful and profitable enterprise with a portfolio covering all the major therapeutic areas.

MSN Groups efficient and well-knit global sales and marketing team of professionals assimilate market trends effectively & market our products in all the major pharmaceutical markets globally. Their professional knowledge and attitude combined with common sense and business acumen have played a pivotal role in surging our sales and revenues.

We have very efficient systems driven supply chain management and a highly responsive customer relationship management team (by michael mosley). In fact, we are the youngest pharmaceutical company in the world to have SAP in place for all our commercial operations. We guarantee competitive edge to our customers because of our absolute cost efficiency and aggressive product development timelines. Along with this commitment comes an irrevocable promise of quality and consistency.

MSN Group seeks to explore and develop more strategic areas to diligently pursue new opportunities and effectively transmit ethically consistent and truthful image of our products.

Share: